Phoenix today announced new appointments to its Board of Directors. Sir William (Bill) Castell has been appointed Vice Chairman of the Board and Dr. Masha Strømme, a Phoenix Director since 2015, has been appointed Chairman, both effective since June 22, 2018. Jan Fikkan, who was instrumental in the establishment of Phoenix since it was spun out of GE Healthcare in 2012, is stepping down as Chairman of the Board and will remain a Director of the Board.
“We are pleased to welcome Bill to Phoenix’s Board and we look forward to Masha’s continued contributions as the new Chairman says Dr. Per Sontum, CEO of Phoenix. “Bill - in his capacity as CEO and Chairman of Amersham – was instrumental in the early development of Phoenix’s microbubble technology. His intimate knowledge of the ACT® technology, deep pharma experience and senior leadership experience will be invaluable to Phoenix”
“I was always eager to see the pursuit of therapeutic payloads to specific sites using the microbubble technology.” Bill continues: “the preclinical data is very compelling, and I look forward to contributing to the further development of the technology as it takes its first step toward the clinic”.